Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Schwartz said it all

While I wasn't there, I know the answer is yes.  It's called acquisition/merger with a company/companies that can provide a positive and recurring cash flow.

I think the litigation determines mainly the scale of the acquisition/merger.

Agree?

Share
New Message
Please login to post a reply